H. Lundbeck A/S (HLBBF)
7.16
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
H. Lundbeck EPS Diluted (Quarterly) : -0.0042 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.9419 |
| ALK-Abello A/S | 0.3088 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.208M |
| Revenue (Quarterly) | 921.52M |
| Total Expenses (Quarterly) | 925.73M |
| Enterprise Value | 8.396B |
| Gross Profit Margin (Quarterly) | 69.59% |
| Profit Margin (Quarterly) | -0.46% |
| Earnings Yield | 6.73% |
| Operating Earnings Yield | 13.55% |
| Normalized Earnings Yield | 7.909 |